• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本通过《脑卒中及心血管病控制法案》:综合性全国防治策略,关注预防、治疗与患者支持。

Approval of Stroke and Cardiovascular Disease Control Act in Japan: Comprehensive nationwide approach for prevention, treatment, and patients' support.

机构信息

Japan Stroke Association, Osaka, Japan.

Japan Stroke Society, Tokyo, Japan.

出版信息

Int J Stroke. 2020 Jan;15(1):7-8. doi: 10.1177/1747493019873549. Epub 2019 Sep 3.

DOI:10.1177/1747493019873549
PMID:31480939
Abstract

The Stroke and Cardiovascular Disease Control Act was enacted in Japan in December 2018. This law has become the first ever legislative countermeasure against stroke and cardiovascular disease in Japan. The government shall make a "Basic Plan to Promote Stroke and Cardiovascular Disease Control Programs" with input from a council consisted of stakeholders. In accordance with the government plan, each prefecture shall make a prefectural plan. Both government and prefectural plans will be reviewed at least every six years. A nationwide approach is expected to contribute to reducing the burden of disease and to prolong healthy life expectancy.

摘要

《脑卒中与心血管病防治法案》于 2018 年 12 月在日本颁布。该法案成为日本防治脑卒中与心血管病的首个立法对策。政府将在一个由利益相关方组成的委员会的参与下,制定一份“促进脑卒中与心血管病控制计划的基本计划”。根据政府计划,每个县都将制定一份县级计划。政府和县级计划都将至少每六年进行一次审查。全国范围内的行动有望有助于减轻疾病负担,延长健康预期寿命。

相似文献

1
Approval of Stroke and Cardiovascular Disease Control Act in Japan: Comprehensive nationwide approach for prevention, treatment, and patients' support.日本通过《脑卒中及心血管病控制法案》:综合性全国防治策略,关注预防、治疗与患者支持。
Int J Stroke. 2020 Jan;15(1):7-8. doi: 10.1177/1747493019873549. Epub 2019 Sep 3.
2
Current Situation and Consideration of Prefectural Plans for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease in Japan - Perspectives on Cardiovascular Disease.日本都道府县促进脑血管病和心血管病防治措施计划的现状与思考——心血管病视角
Circ J. 2025 Apr 25;89(5):543-549. doi: 10.1253/circj.CJ-24-0211. Epub 2024 Apr 27.
3
[Future Outlook of the Stroke Medical Care System Based on the Stroke and Cardiovascular Disease Control Act in Japan].[基于日本《脑卒中与心血管疾病控制法》的脑卒中医疗体系的未来展望]
No Shinkei Geka. 2021 Mar;49(2):445-451. doi: 10.11477/mf.1436204412.
4
[Japanese National Plan for Promotion of Measures against Stroke and Cardiovascular Diseases and Data-Based Health Management Initiatives].[日本促进中风和心血管疾病防治措施及基于数据的健康管理倡议国家计划]
No Shinkei Geka. 2024 Mar;52(2):433-447. doi: 10.11477/mf.1436204930.
5
[The basic plan to promote cancer control in Japan].[日本促进癌症控制的基本计划]
Gan To Kagaku Ryoho. 2013 May;40(5):559-64.
6
[Amendment of tuberculosis prevention law and prospect of tuberculosis control program].[结核病预防法的修订与结核病控制规划的前景]
Kekkaku. 2005 Jul;80(7):541-6.
7
Registry Studies of Stroke in Japan.日本的中风登记研究。
J Atheroscler Thromb. 2023 Sep 1;30(9):1095-1103. doi: 10.5551/jat.RV22008. Epub 2023 Jul 19.
8
[Reform of Japan's NTP and its technical perspectives].[日本国家毒理学计划的改革及其技术视角]
Kekkaku. 2004 Oct;79(10):587-604.
9
[The new Tuberculosis Control Program of Japan].[日本新的结核病控制项目]
Kansenshogaku Zasshi. 2006 Jul;80(4):345-52. doi: 10.11150/kansenshogakuzasshi1970.80.345.
10
[Future direction of medical care system for patients with infectious disease and the new infectious diseases control law in Japan--centering around a category 1 hospital].[日本传染病患者医疗体系的未来方向与新传染病控制法——以一家一级医院为中心]
Kansenshogaku Zasshi. 2000 Sep;74(9):687-93. doi: 10.11150/kansenshogakuzasshi1970.74.687.

引用本文的文献

1
Trends in stroke incidence and mortality in China, Japan, and South Korea (1990-2021) with projections to 2035.中国、日本和韩国1990 - 2021年中风发病率和死亡率趋势及2035年预测。
Sci Rep. 2025 Jul 14;15(1):25370. doi: 10.1038/s41598-025-10840-2.
2
A Systematic Analysis of Additive Manufacturing Techniques in the Bioengineering of In Vitro Cardiovascular Models.增材制造技术在体外心血管模型生物工程中的系统分析。
Ann Biomed Eng. 2023 Nov;51(11):2365-2383. doi: 10.1007/s10439-023-03322-x. Epub 2023 Jul 19.
3
Current status and future aspects in the Japan Stroke Data Bank.
日本卒中数据库的现状与未来展望
Front Neurol. 2023 Mar 22;14:1090136. doi: 10.3389/fneur.2023.1090136. eCollection 2023.
4
Association of Major Chronic Noncommunicable Diseases and Life Expectancy in China, 2019.2019年中国主要慢性非传染性疾病与预期寿命的关联
Healthcare (Basel). 2022 Feb 3;10(2):296. doi: 10.3390/healthcare10020296.
5
Harmonization of Cardiovascular and Oncology and the Blossoming of Cardio-Oncology in Japan.日本心血管与肿瘤学的协调发展及心脏肿瘤学的蓬勃兴起。
JACC CardioOncol. 2020 Dec 15;2(5):819-821. doi: 10.1016/j.jaccao.2020.11.011. eCollection 2020 Dec.
6
Cardio-Oncology in Japan: The Rapidly Rising Sun.日本的心脏肿瘤学:旭日东升。
JACC CardioOncol. 2020 Dec 15;2(5):815-818. doi: 10.1016/j.jaccao.2020.10.014. eCollection 2020 Dec.
7
Implementation of a telestroke system for general physicians without a nearby stroke center to shorten the time to intravenous thrombolysis for acute cerebral infarction.为附近没有卒中中心的普通内科医生实施远程卒中系统,以缩短急性脑梗死静脉溶栓的时间。
Acute Med Surg. 2020 Aug 13;7(1):e551. doi: 10.1002/ams2.551. eCollection 2020 Jan-Dec.
8
The dawning of the digital era in the management of hypertension.数字时代在高血压管理中的兴起。
Hypertens Res. 2020 Nov;43(11):1135-1140. doi: 10.1038/s41440-020-0506-1. Epub 2020 Jul 13.
9
Small but Steady Steps in Stroke Medicine in Japan.日本中风医学领域的小而稳健的步伐。
J Am Heart Assoc. 2019 Aug 20;8(16):e013306. doi: 10.1161/JAHA.119.013306. Epub 2019 Aug 8.